The main adverse events related to high dose ribavirin were reversible hemolytic anemia and hypomagnesemia in patients with hemorrhagic fever with renal syndrome. |
Ribavirin is an antiviral that is approved for treating young children with severe lower respiratory tract infections due to respiratory syncytial virus. |
The study involves 54 patients receiving telaprevir in combination with peginterferon and another treatment, ribavirin. |
The broad spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. |
After three days of ribavirin treatment bradycardia developed. |
The new drugs, sofosbuvir and simeprevir, are each approved for use with interferon and ribavirin for treatment of genotype 1 infection. |